View in EDS HTML Full Text PDF Full Text

Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials.

Saved in:
Bibliographic Details
Title: Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials.
Authors: Almansour SA; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates., Alqudah MAY; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan., Abuhelwa Z; Department of Hematology and Medical Oncology, University of South Florida/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Al-Shamsi HO; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.; College of Medicine, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.; Emirates Oncology Society, Dubai, United Arab Emirates.; Gulf Medical University, Ajman, United Arab Emirates.; Gulf Cancer Society, Alsafa, Kuwait., Alhuraiji A; Department of Haematology, Kuwait Cancer Control Center, Kuwait., Semreen MH; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.; Department of Medicinal Chemistry, University of Sharjah, Sharjah, United Arab Emirates., Bustanji Y; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; School of Pharmacy, The University of Jordan, Amman, Jordan., Alzoubi KH; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates., Modi ND; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Mckinnon RA; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Sorich MJ; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Hopkins AM; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia., Abuhelwa AY; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Sep 02; Vol. 16, pp. 17588359241275387. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39229471
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Almansour+SA%22">Almansour SA</searchLink>; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Alqudah+MAY%22">Alqudah MAY</searchLink>; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Abuhelwa+Z%22">Abuhelwa Z</searchLink>; Department of Hematology and Medical Oncology, University of South Florida/H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Al-Shamsi+HO%22">Al-Shamsi HO</searchLink>; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates.; College of Medicine, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.; Emirates Oncology Society, Dubai, United Arab Emirates.; Gulf Medical University, Ajman, United Arab Emirates.; Gulf Cancer Society, Alsafa, Kuwait.<br /><searchLink fieldCode="AU" term="%22Alhuraiji+A%22">Alhuraiji A</searchLink>; Department of Haematology, Kuwait Cancer Control Center, Kuwait.<br /><searchLink fieldCode="AU" term="%22Semreen+MH%22">Semreen MH</searchLink>; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.; Department of Medicinal Chemistry, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Bustanji+Y%22">Bustanji Y</searchLink>; College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.; School of Pharmacy, The University of Jordan, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Alzoubi+KH%22">Alzoubi KH</searchLink>; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Modi+ND%22">Modi ND</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Mckinnon+RA%22">Mckinnon RA</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Sorich+MJ%22">Sorich MJ</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Hopkins+AM%22">Hopkins AM</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Abuhelwa+AY%22">Abuhelwa AY</searchLink>; Department of Pharmacy Practice and Pharmacotherapeutics, University of Sharjah, Sharjah, United Arab Emirates.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2024 Sep 02; Vol. 16, pp. 17588359241275387. <i>Date of Electronic Publication: </i>2024 Sep 02 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39229471
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17588359241275387
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17588359241275387
    Titles:
      – TitleFull: Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Almansour SA
      – PersonEntity:
          Name:
            NameFull: Alqudah MAY
      – PersonEntity:
          Name:
            NameFull: Abuhelwa Z
      – PersonEntity:
          Name:
            NameFull: Al-Shamsi HO
      – PersonEntity:
          Name:
            NameFull: Alhuraiji A
      – PersonEntity:
          Name:
            NameFull: Semreen MH
      – PersonEntity:
          Name:
            NameFull: Bustanji Y
      – PersonEntity:
          Name:
            NameFull: Alzoubi KH
      – PersonEntity:
          Name:
            NameFull: Modi ND
      – PersonEntity:
          Name:
            NameFull: Mckinnon RA
      – PersonEntity:
          Name:
            NameFull: Sorich MJ
      – PersonEntity:
          Name:
            NameFull: Hopkins AM
      – PersonEntity:
          Name:
            NameFull: Abuhelwa AY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Sep 02
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1